Is intravenous ketorolac 30 mg appropriate for a normotensive patient with marked tachycardia and possible allergic or asthmatic reaction?

Ketorolac 30mg is CONTRAINDICATED in this clinical scenario

Do not administer ketorolac 30mg to a patient with marked tachycardia and possible allergic or asthmatic reaction. This represents a potentially life-threatening situation where ketorolac could precipitate severe bronchospasm, worsen the allergic reaction, or trigger anaphylaxis.

Why Ketorolac is Dangerous Here

Direct Risk of Bronchospasm in Asthma/Allergic Reactions

• Ketorolac is an NSAID that can precipitate severe, life-threatening bronchospasm in asthmatic patients 1, 2, 3
• Fatal cases have been documented: A case report describes an asthmatic woman who collapsed within minutes of intramuscular ketorolac injection, dying from acute bronchospasm and cardiac arrest 3
• Severe ketorolac-induced asthma requiring CT diagnosis has been reported, with bilateral mucoid impaction and sub-segmental atelectasis 1
• The FDA label does not list asthma as an absolute contraindication, but clinical evidence strongly suggests avoiding it in active bronchospasm 4

Risk of Anaphylaxis

• Multiple case reports document ketorolac-induced anaphylaxis with urticaria, tachycardia, breathing difficulty, and oxygen desaturation 5, 6, 7
• Anaphylaxis can occur even without prior NSAID allergy history 1
• One patient developed severe anaphylaxis after ketorolac despite previously tolerating diclofenac and nimesulid 1

Tachycardia Complicates Management

• The marked tachycardia suggests either:
  • Anaphylaxis in progress (compensatory tachycardia from vasodilation/hypotension)
  • Severe asthma exacerbation (hypoxia-driven tachycardia)
  • Impending cardiovascular collapse
• Adding ketorolac could worsen bronchospasm, triggering further tachycardia and potential cardiac arrest

What to Do Instead

Immediate Priority: Treat the Allergic/Asthmatic Reaction

If anaphylaxis is suspected (urticaria, angioedema, bronchospasm, hypotension):

1. Administer intramuscular epinephrine 0.3-0.5mg immediately - this is the first-line treatment with no absolute contraindications 8
2. Position patient supine (or in position of comfort if respiratory distress)
3. Administer high-flow oxygen 8
4. Establish IV access and give rapid crystalloid bolus (500-1000mL) 9
5. Consider H1 antihistamines and corticosteroids as adjuncts (NOT priorities) 8

If severe bronchospasm without other anaphylaxis features:

1. Administer inhaled bronchodilators (albuterol/salbutamol)
2. Provide supplemental oxygen
3. Consider IV corticosteroids
4. Epinephrine if refractory to bronchodilators 9

Pain Management Alternatives

For normotensive patients with tachycardia needing analgesia:

• Acetaminophen IV 1000mg - safe, no effect on platelets or renal function, no bronchospasm risk 10
• Opioids (morphine, fentanyl) - carefully titrated, monitor for respiratory depression
• Avoid all NSAIDs including ketorolac, ibuprofen, naproxen in this acute setting

Critical Pitfalls to Avoid

1. Never assume prior NSAID tolerance means safety - patients can develop new sensitivities 1
2. Don't delay epinephrine in anaphylaxis due to tachycardia concerns - the tachycardia is likely FROM the anaphylaxis, and epinephrine is life-saving despite theoretical arrhythmia risk 8, 11
3. Don't give ketorolac "just for pain" when respiratory/allergic symptoms are present - the mortality risk far outweighs analgesic benefit
4. Recognize that IV/IM ketorolac acts within 30 minutes - reactions can be rapid and severe 5, 6

Bottom Line

In a patient with marked tachycardia and possible allergic or asthmatic reaction, ketorolac 30mg IV is absolutely inappropriate and potentially lethal. Focus on treating the underlying allergic/asthmatic process with epinephrine, oxygen, fluids, and bronchodilators. Use acetaminophen or carefully titrated opioids for pain management instead.